The structures of nucleic acid therapeutics are often chemically modified at the base, phosphate, and sugar moieties to achieve enhanced nuclease resistance and improved hybridization property. 4'-Thionucleic acids are nucleic acids (DNA, RNA) chemically modified at the sugar moiety, exhibiting higher duplex-forming ability and greater nuclease resistance compared to their natural counterparts.1)